Kezar Life Sciences Inc (KZR)
7.55
+0.01
(+0.13%)
USD |
NASDAQ |
Nov 14, 16:00
7.55
0.00 (0.00%)
After-Hours: 16:47
Kezar Life Sciences Price to Book Value: 0.3656 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 0.3651 |
| November 12, 2024 | 0.3627 |
| November 11, 2024 | 0.3602 |
| November 08, 2024 | 0.3569 |
| November 07, 2024 | 0.3588 |
| November 06, 2024 | 0.3598 |
| November 05, 2024 | 0.3535 |
| November 04, 2024 | 0.3433 |
| November 01, 2024 | 0.3491 |
| October 31, 2024 | 0.3607 |
| October 30, 2024 | 0.3966 |
| October 29, 2024 | 0.3633 |
| October 28, 2024 | 0.374 |
| October 25, 2024 | 0.3804 |
| October 24, 2024 | 0.3882 |
| October 23, 2024 | 0.3888 |
| October 22, 2024 | 0.3777 |
| October 21, 2024 | 0.3836 |
| October 18, 2024 | 0.3989 |
| October 17, 2024 | 0.3951 |
| October 16, 2024 | 0.4332 |
| October 15, 2024 | 0.4213 |
| October 14, 2024 | 0.4213 |
| October 11, 2024 | 0.4104 |
| October 10, 2024 | 0.4133 |
| Date | Value |
|---|---|
| October 09, 2024 | 0.4185 |
| October 08, 2024 | 0.3583 |
| October 07, 2024 | 0.3748 |
| October 04, 2024 | 0.3862 |
| October 03, 2024 | 0.3998 |
| October 02, 2024 | 0.4019 |
| October 01, 2024 | 0.3829 |
| September 30, 2024 | 0.3744 |
| September 27, 2024 | 0.2634 |
| September 26, 2024 | 0.2559 |
| September 25, 2024 | 0.2658 |
| September 24, 2024 | 0.2673 |
| September 23, 2024 | 0.2743 |
| September 20, 2024 | 0.2763 |
| September 19, 2024 | 0.2821 |
| September 18, 2024 | 0.2791 |
| September 17, 2024 | 0.2784 |
| September 16, 2024 | 0.2774 |
| September 13, 2024 | 0.276 |
| September 12, 2024 | 0.2745 |
| September 11, 2024 | 0.2799 |
| September 10, 2024 | 0.2712 |
| September 09, 2024 | 0.2747 |
| September 06, 2024 | 0.2709 |
| September 05, 2024 | 0.2808 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2414
Minimum
Nov 10 2023
7.280
Maximum
Dec 30 2021
1.621
Average
1.588
Median
Oct 06 2020
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.8831 |
| Theriva Biologics Inc | 0.0530 |
| Oragenics Inc | -- |
Price to Book Value Related Metrics
| Price | 7.55 |
| Earnings Yield | -180.1% |
| Market Cap | 55.09M |